Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
Current unprecedented mpox outbreaks in non-endemic regions represent a global public health concern. Although two live-attenuated vaccinia virus (VACV)-based vaccines have been urgently approved for people at high risk for mpox, a safer and more effective vaccine that can be available for the gener...
Saved in:
| Main Authors: | Jiawei Zeng, Yao Li, Linrui Jiang, Ling Luo, Yue Wang, Hao Wang, Xiaonan Han, Jian Zhao, Guanglei Gu, Min Fang, Qingrui Huang, Jinghua Yan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2023.2204151 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Mpox Multi-Antigen-Tandem Bivalent mRNA Candidate Vaccine Effectively Protects Mice Against the Vaccinia Virus
by: Jun Zuo, et al.
Published: (2025-03-01) -
Rational development of multicomponent mRNA vaccine candidates against mpox
by: Rong-Rong Zhang, et al.
Published: (2023-12-01) -
A Single-Chain Mpox mRNA Vaccine Elicits Protective Immune Response in Mice
by: Qian Xu, et al.
Published: (2025-05-01) -
mRNA Vaccine Against Mpox: A Promising Healthcare Strategy
by: Mohammad Shah Alam, et al.
Published: (2025-05-01) -
Detection of mpox and other orthopoxviruses using a lateral flow device as a point-of-care diagnostic
by: Stephen M. Laidlaw, et al.
Published: (2025-04-01)